Literature DB >> 34243920

Abbreviated MR Protocols for Chronic Liver Disease and Liver Cancer.

Guillermo Carbonell1, Bachir Taouli2.   

Abstract

MR imaging has become a powerful tool for assessing liver disease and liver cancer; however, it entails complex, time-consuming, and costly protocols. Abbreviated MR imaging (AMRI) is emerging as a simpler, faster, and low-cost alternative to full-abdominal MR imaging protocols. Different AMRI approaches have been tested successfully in hepatocellular carcinoma detection and for assessment of diffuse liver disease. The most accurate, time-effective, and cost-effective protocol as well as the target population need to be defined. Prospective and multicentric studies, exploring different AMRI protocols versus the current standard of reference, should be performed.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Abbreviated magnetic resonance imaging; Fat; Fibrosis; Hepatocellular carcinoma; Screening

Mesh:

Substances:

Year:  2021        PMID: 34243920      PMCID: PMC8274313          DOI: 10.1016/j.mric.2021.05.003

Source DB:  PubMed          Journal:  Magn Reson Imaging Clin N Am        ISSN: 1064-9689            Impact factor:   1.376


  47 in total

1.  CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis.

Authors:  Nam C Yu; Vinika Chaudhari; Steven S Raman; Charles Lassman; Myron J Tong; Ronald W Busuttil; David S K Lu
Journal:  Clin Gastroenterol Hepatol       Date:  2010-10-01       Impact factor: 11.382

2.  Comparison of diagnostic performance of non-contrast MRI and abbreviated MRI using gadoxetic acid in initially diagnosed hepatocellular carcinoma patients: a simulation study of surveillance for hepatocellular carcinomas.

Authors:  Sunyoung Whang; Moon Hyung Choi; Joon-Il Choi; Seo Yeon Youn; Dong Hwan Kim; Sung Eun Rha
Journal:  Eur Radiol       Date:  2020-03-12       Impact factor: 5.315

3.  Abbreviated-protocol screening MRI vs. complete-protocol diagnostic MRI for detection of hepatocellular carcinoma in patients with cirrhosis: An equivalence study using LI-RADS v2018.

Authors:  Gaurav Khatri; Ivan Pedrosa; Lakshmi Ananthakrishnan; Alberto Diaz de Leon; David T Fetzer; John Leyendecker; Amit G Singal; Yin Xi; Adam Yopp; Takeshi Yokoo
Journal:  J Magn Reson Imaging       Date:  2019-06-18       Impact factor: 4.813

4.  Abbreviated protocol for breast MRI: are multiple sequences needed for cancer detection?

Authors:  Victoria L Mango; Elizabeth A Morris; D David Dershaw; Andrea Abramson; Charles Fry; Chaya S Moskowitz; Mary Hughes; Jennifer Kaplan; Maxine S Jochelson
Journal:  Eur J Radiol       Date:  2014-10-16       Impact factor: 3.528

5.  Cost-Utility Analysis of Imaging for Surveillance and Diagnosis of Hepatocellular Carcinoma.

Authors:  Paulo Henrique Lima; Boyan Fan; Joshua Bérubé; Milena Cerny; Damien Olivié; Jeanne-Marie Giard; Catherine Beauchemin; An Tang
Journal:  AJR Am J Roentgenol       Date:  2019-04-17       Impact factor: 3.959

6.  Diagnostic per-patient accuracy of an abbreviated hepatobiliary phase gadoxetic acid-enhanced MRI for hepatocellular carcinoma surveillance.

Authors:  Robert M Marks; Andrew Ryan; Elhamy R Heba; An Tang; Tanya J Wolfson; Anthony C Gamst; Claude B Sirlin; Mustafa R Bashir
Journal:  AJR Am J Roentgenol       Date:  2015-03       Impact factor: 3.959

7.  Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review.

Authors:  Agostino Colli; Mirella Fraquelli; Giovanni Casazza; Sara Massironi; Alice Colucci; Dario Conte; Piergiorgio Duca
Journal:  Am J Gastroenterol       Date:  2006-03       Impact factor: 10.864

8.  GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score.

Authors:  Ju Dong Yang; Benyam D Addissie; Kristin C Mara; William S Harmsen; Jianliang Dai; Ning Zhang; Nicha Wongjarupong; Hawa M Ali; Hamdi A Ali; Fatima A Hassan; Sravanthi Lavu; Jessica L Cvinar; Nasra H Giama; Catherine D Moser; Katsuyuki Miyabe; Loretta K Allotey; Alicia Algeciras-Schimnich; J Paul Theobald; Melissa M Ward; Mindie H Nguyen; Alex S Befeler; K Rajender Reddy; Myron Schwartz; Denise M Harnois; Hiroyuki Yamada; Sudhir Srivastava; Jo Ann Rinaudo; Gregory J Gores; Ziding Feng; Jorge A Marrero; Lewis R Roberts
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-11-21       Impact factor: 4.090

9.  Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma.

Authors:  Jiabin Cai; Lei Chen; Zhou Zhang; Xinyu Zhang; Chuan He; Hongyang Wang; Wei Zhang; Jia Fan; Xingyu Lu; Weiwei Liu; Guoming Shi; Yang Ge; Pingting Gao; Yuan Yang; Aiwu Ke; Linlin Xiao; Ruizhao Dong; Yanjing Zhu; Xuan Yang; Jiefei Wang; Tongyu Zhu; Deping Yang; Xiaowu Huang; Chengjun Sui; Shuangjian Qiu; Feng Shen; Huichuan Sun; Weiping Zhou; Jian Zhou; Ji Nie; Chang Zeng; Emily Kunce Stroup; Xu Zhang; Brian C-H Chiu; Wan Yee Lau
Journal:  Gut       Date:  2019-07-29       Impact factor: 31.793

10.  The Diagnostic Performance of Liver MRI without Intravenous Contrast for Detecting Hepatocellular Carcinoma: A Case-Controlled Feasibility Study.

Authors:  Seunghee Han; Joon-Il Choi; Michael Yong Park; Moon Hyung Choi; Sung Eun Rha; Young Joon Lee
Journal:  Korean J Radiol       Date:  2018-06-14       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.